<<

continuing education

Continuing Education quiz information

To receive continuing education credit, please note the following information:

1.  Complete the participant information in the spaces provided. Use BLUE ink only. 2.  Mail the completed form for scoring to the address listed below. The quiz must be postmarked by the expiration date. Faxed CE quizzes WILL NOT be accepted. Mail to: APA,1211 Carmichael Way, Montgomery, AL 36106 3. CE processing is free for APA members. Non-members must include a processing fee of $20 per quiz. 4. No more than 3 quizzes will be accepted per month per individual. 5.  Credit will be awarded for a passing grade of 80% or better. If you fail the exam, you may retake it once, and corrected answers must be in RED ink.

www.aPARX.org 59 continuing education quiz - ACPE#: 0178-0000-12-112-H01-P

1. In 2008, obesity related medical costs were approximately ______. 10. Adipex-P cannot be phoned in to the pharmacy from the a. $1 billion physician’s office. b. $240 billion a. True c. $147 billion b. False d. $500 billion

11. Which one of the following Schedules of medications cannot be used 2. Which of the following combinations represents states with the highest for weight loss? percentage of obese people (BMI ≥30%) a. II a. Mississippi, Hawaii, Montanta b. III b. Alabama, Louisiana, Oklahoma c. IV c. Washington, Utah, New York d. V d. Texas, Michigan,Vermont

12. Roux-en-Y gastric bypass is more beneficial than lap band surgery 3. What percentage of calories is burned throughout the day without due to its lack of malabsorption. exercising in a typical adults? a. True a. 20% b. False b. 45% c. 60% d. 70% 13. causes weight loss due to nausea and diarrhea. a. True b. False 4. A body mass index of 27 kg/m2 is classified as: a. Underweight b. Normal weight 14. Bitter orange is: c. Overweight a. /energy booster d. Obese b. Fat/carbohydrate modulator c. Appetite suppressant/satiety promoter d. Laxative/diuretic 5. The best tool to assess obesity is: a. Waist-to-height ratio b. Body mass index 15. Which one of the following medications was removed from the market c. Waist circumference NOT due to cardiac effects? d. Assessing one’s risk for cardiovascular disease a. Meridia () b. Pondimiun () c. Redux () 6. Which of the following is NOT considered a cardiovascular risk factor: d. Sanorex () a. Elevated LDL cholesterol b. Cigarette smoking c. Lack of adequate exercise 16. Which one of the following new medications currently in research has d. Family history of coronary heart disease a mechanism of action of selective serotonin 2C agonism? a. Lorqess () b. Contrave (/) 7. Which of the following is NOT considered a risk factor that identifies a c. patient at a very high risk of mortality? d. a. Hypertension b. History of myocardial infarction c. Coronary artery surgery or procedure 17. Which of the following new medications currently in research is an d. Type II diabetes analogue of two natural hormones? a. Tesofensine b. Obinepitide 8. The diet that produces the most significant weight loss and weight c. Velneperit maintenance is: d. Qnexa (/topirimate) a. Very low calorie diet b. Low calorie diet c. Low fat diet 18. The combination product of and bupropion is: d. Low carbohydrate diet a. Qnexa b. Lorqess c. Contrave 9. Which of the following centrally-acting is safest to use d. Empatic during pregnancy? a. Phentermine b. Diethylproprion c. d.

60 Alabama pHARMACY ASSOCIATION winter 2012 CONTINUING EDUCATION QUIZ - OBESITY | ACPE#: 0178-0000-12-112-H01-P

Participant Information: al license #______CE Assessment Answers Name______Please circle your answers (one answer per question). address______City______State_____ Zip______1. a b C D e-mail______2. a b C D NabP e-Profi le #______3. a b C D mm/DD (month/day of birth)______4. a b C D How long did it take you to read the program and complete this test? 5. a b C D ______hours ______minutes 6. a b C D my signature certifi es that I have independently taken this Ce examination. 7. a b C D ______8. a b C D 9. a b C D 10. a b NOTE: 11. a b C D 12. a b APA WILL 13. a b UPLOAD CREDIT 14. a b C D 15. a b C D INFORMATION 16. a b C D 17. a b C D for this CE TO 18. a b C D CPE MONITOR.

www.aPaRX.oRg 61